DK170617B1 - Pyrazinoxidforbindelse NF-1616-904, fremgangsmåde til fremstilling heraf og farmaceutiske præparater indeholdende denne - Google Patents

Pyrazinoxidforbindelse NF-1616-904, fremgangsmåde til fremstilling heraf og farmaceutiske præparater indeholdende denne Download PDF

Info

Publication number
DK170617B1
DK170617B1 DK446388A DK446388A DK170617B1 DK 170617 B1 DK170617 B1 DK 170617B1 DK 446388 A DK446388 A DK 446388A DK 446388 A DK446388 A DK 446388A DK 170617 B1 DK170617 B1 DK 170617B1
Authority
DK
Denmark
Prior art keywords
oxide compound
compound
pyrazine
pyrazine oxide
preparation
Prior art date
Application number
DK446388A
Other languages
Danish (da)
English (en)
Other versions
DK446388D0 (da
DK446388A (da
Inventor
Yoshimasa Nakano
Michiharu Sugawara
Setsuyoshi Uetsuki
Taketoshi Izawa
Tomoyuki Kawaguchi
Akira Wada
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of DK446388D0 publication Critical patent/DK446388D0/da
Publication of DK446388A publication Critical patent/DK446388A/da
Application granted granted Critical
Publication of DK170617B1 publication Critical patent/DK170617B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/165—Heterorings having nitrogen atoms as the only ring heteroatoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK446388A 1987-08-11 1988-08-10 Pyrazinoxidforbindelse NF-1616-904, fremgangsmåde til fremstilling heraf og farmaceutiske præparater indeholdende denne DK170617B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20153787 1987-08-11
JP20153787 1987-08-11

Publications (3)

Publication Number Publication Date
DK446388D0 DK446388D0 (da) 1988-08-10
DK446388A DK446388A (da) 1989-02-12
DK170617B1 true DK170617B1 (da) 1995-11-13

Family

ID=16442692

Family Applications (1)

Application Number Title Priority Date Filing Date
DK446388A DK170617B1 (da) 1987-08-11 1988-08-10 Pyrazinoxidforbindelse NF-1616-904, fremgangsmåde til fremstilling heraf og farmaceutiske præparater indeholdende denne

Country Status (9)

Country Link
US (1) US5021419A (ko)
EP (1) EP0303250B1 (ko)
JP (1) JPH01131177A (ko)
KR (1) KR960005150B1 (ko)
CN (1) CN1028655C (ko)
DE (1) DE3880231T2 (ko)
DK (1) DK170617B1 (ko)
ES (1) ES2054748T3 (ko)
MX (1) MX9202936A (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69029231T2 (de) 1989-02-10 1997-03-20 Otsuka Pharma Co Ltd Indolderivate, ihre herstellung und diese enthaltendes arzneimittel zum verhindern und behandeln von nephritis
US5238938A (en) * 1989-02-10 1993-08-24 Otsuka Pharmaceutical Co., Ltd. Indole derivatives
CN1038586C (zh) * 1991-05-01 1998-06-03 大制药株式会社 吡嗪衍生物的制备方法
SE529897C2 (sv) 2006-03-27 2007-12-27 Rottneros Ab Formpressat tråg

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427735D0 (en) * 1984-11-02 1984-12-12 Fujisawa Pharmaceutical Co Piperazine compound

Also Published As

Publication number Publication date
DE3880231T2 (de) 1993-10-07
DK446388D0 (da) 1988-08-10
CN1032031A (zh) 1989-03-29
ES2054748T3 (es) 1994-08-16
EP0303250A2 (en) 1989-02-15
JPH01131177A (ja) 1989-05-24
KR960005150B1 (ko) 1996-04-22
US5021419A (en) 1991-06-04
EP0303250B1 (en) 1993-04-14
JPH0557273B2 (ko) 1993-08-23
KR890003734A (ko) 1989-04-17
DK446388A (da) 1989-02-12
EP0303250A3 (en) 1990-07-11
MX9202936A (es) 1992-06-30
DE3880231D1 (de) 1993-05-19
CN1028655C (zh) 1995-05-31

Similar Documents

Publication Publication Date Title
JPH07165578A (ja) 血管再発狭窄症の抑制法
WO1997039999A1 (fr) Nouveaux composes de terphenyl et medicaments contenant ces composes
CN109232684B (zh) 17-aag葡萄糖苷及其制备方法和在制备抗肿瘤药物中的应用
DK170617B1 (da) Pyrazinoxidforbindelse NF-1616-904, fremgangsmåde til fremstilling heraf og farmaceutiske præparater indeholdende denne
KR0135600B1 (ko) 항암 항생물질 mi43-37f11, 그 제조방법 및 그 용도
JPH06506202A (ja) 医薬用キサントン誘導体
DK154704B (da) Fremgangsmaade til fremstilling af et sesquiterpenderivat eller salte deraf
SU1074408A3 (ru) Способ получени 3-0/ @ - @ -глукуронпиранозил/-со сапогенола
CN101723997A (zh) 葛根素糖基化衍生物、其药物组合物、及其制备方法和用途
US4831053A (en) Composition for prophylaxis and therapy of hepatitis
JPH0625069A (ja) 抗菌、抗ウイルスおよび抗腫瘍抗生物質ｂｕ−４６４１ｖ
US6645996B1 (en) Physiologically active substances
US5338758A (en) Bicyclic diterpene PAF antagonist compounds
CN108546247B (zh) 一种生物碱类化合物在制备抗肥胖药物中用途
RU2221870C2 (ru) Мумбайстатин, способ его получения и его применение в качестве фармацевтического препарата
JP3719689B2 (ja) 新規物質トリプロスタチン、その製造方法、細胞周期阻害剤および抗腫瘍剤
JP2003503412A (ja) 海洋放線菌に由来する新規のインドロカルバゾールアルカロイド
JP3688446B2 (ja) 新規テルペン系化合物０４０６ｔｐ−１
JPH01149766A (ja) インドール誘導体
JP4833461B2 (ja) 新規血管新生阻害剤
WO2000032604A1 (fr) Composes de macrolides et methodes d'evaluation d'immunodeprimants
JPH07506332A (ja) 医薬としての複素環化合物のリン酸エステル
JPH03290193A (ja) 生理活性物質ｔａｎ―１３２３、その製造法および用途
JPH0987269A (ja) アセトフタリジン、細胞周期阻害剤および抗腫瘍剤
EP0537199A1 (en) Compositions for treating hiv-type 1 infection

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed